BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pierri F, Dufour C. Management of aplastic anemia after failure of frontline immunosuppression. Expert Rev Hematol 2019;12:809-19. [PMID: 31311355 DOI: 10.1080/17474086.2019.1645003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang FK. [How I treat refractory sever aplastic anemia]. Zhonghua Xue Ye Xue Za Zhi 2020;41:705-9. [PMID: 33113600 DOI: 10.3760/cma.j.issn.0253-2727.2020.09.001] [Reference Citation Analysis]
2 Feng FE, Zhang GC, Liu FQ, He Y, Zhu XL, Liu X, Wang Y, Wang JZ, Fu HX, Chen YH, Han W, Chang YJ, Xu LP, Liu KY, Huang XJ, Zhang XH. HCMV modulates c-Mpl/IEX-1 pathway-mediated megakaryo/thrombopoiesis via PDGFRα and αvβ3 receptors after allo-HSCT. J Cell Physiol 2021;236:6726-41. [PMID: 33611789 DOI: 10.1002/jcp.30335] [Reference Citation Analysis]
3 Gao Q, Zhang L, Zhao X, Zhu Y, Peng G, Li Y, Li Y, Li J, Song L, Ye L, Fan H, Zhou K, Yang W, Yang Y, Jing L, Zhang F. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia. Hematology 2020;25:341-7. [PMID: 32915111 DOI: 10.1080/16078454.2020.1815129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Yang Y, Ji J, Tang Z, Han B. Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review. Front Oncol 2021;11:614965. [PMID: 33981596 DOI: 10.3389/fonc.2021.614965] [Reference Citation Analysis]
5 Ghosh K, Ghosh K. Monoclonal antibodies used for the management of haematological disorders. Expert Rev Hematol 2022. [PMID: 35504000 DOI: 10.1080/17474086.2022.2073213] [Reference Citation Analysis]
6 Du Y, Huang Y, Zhou W, Liu X, Chen F, Yang C, Chen M, Ruan J, Han B. Effective Tacrolimus Treatment for Patients with Non-Severe Aplastic Anemia That is Refractory/Intolerant to Cyclosporine A: A Retrospective Study. Drug Des Devel Ther 2020;14:5711-9. [PMID: 33408460 DOI: 10.2147/DDDT.S275975] [Reference Citation Analysis]
7 Wang ZJ, Chen HB, Zhou F, Yu H, Wu XY, Shen YQ, Qiu YN, Jin RM. A New Immunosuppressive Therapy for Very Severe Aplastic Anemia in Children with Autoantibodies. Curr Med Sci 2022. [PMID: 35258748 DOI: 10.1007/s11596-022-2519-2] [Reference Citation Analysis]
8 Tonglin H, Yanna Z, Xiaoling Y, Ruilan G, Liming Y. Single-Cell RNA-Seq of Bone Marrow Cells in Aplastic Anemia. Front Genet 2021;12:745483. [PMID: 35046994 DOI: 10.3389/fgene.2021.745483] [Reference Citation Analysis]